Wuhan nuclear medicine docs give COVID-19 safety advice
March 31, 2020 -- Nuclear medicine technologists from Wuhan, China, the epicenter of the COVID-19 outbreak, have published safety precautions for dealing with patients, staff, and equipment during the pandemic in a March 25 article in the European Journal of Nuclear Medicine and Molecular Imaging.  Discuss
Digital FDG-PET offers insights to hearing loss
March 30, 2020 -- The use of digital PET to measure FDG uptake in the area of the brain devoted to hearing can help diagnose asymmetrical hearing loss and gauge the potential efficacy of a cochlear implant, according to a study published in the March issue of the Journal of Nuclear Medicine.  Discuss
PSMA-PET/CT again shows prowess for prostate cancer
March 25, 2020 -- Prostate-specific membrane antigen (PMSA)-PET/CT could become the primary modality approach in confirming the extent of prostate cancer and the most efficient way to direct patients to the most appropriate treatment, according to a study published March 22 in the Lancet.  Discuss
FDG-PET leads prediction on neuroendocrine tumor outcomes
March 18, 2020 -- FDG-PET has again proved its value by correlating positive neuroendocrine tumors in patients treated with peptide receptor radionuclide therapy (PRRT) to their chances of overall and progression-free survival, according to a study published March 13 in the Journal of Nuclear Medicine.  Discuss
IMV: PET scan volume continues growing at steady pace
March 10, 2020 -- Procedure volume in the PET market is continuing to grow at about 6% per year in the U.S. since 2013, reaching its highest level ever in the U.S. in 2019, according to a new report by IMV Medical Information Division.  Discuss
Choline-PET boosts mpMRI for prostate cancer detection
March 5, 2020 -- The addition of F-18 choline PET to multiparametric MRI (mpMRI) can significantly improve the detection of higher-risk primary prostate cancer and assessment of patients with suspected cases, according to a study published in the March issue of the Journal of Nuclear Medicine.  Discuss
Flortaucipir-PET, blood samples link brain injuries to CTE
February 26, 2020 -- Flortaucipir-PET and blood tests have correlated two key biomarkers of chronic traumatic encephalopathy (CTE) in military personnel who experienced traumatic brain injuries from blasts, according to a study published online on February 25 in Molecular Psychiatry.  Discuss
PET shows connection with widowhood, Alzheimer's decline
February 26, 2020 -- Men and women who had been widowed and who had elevated beta-amyloid levels on PET scans were also more likely to have accelerated cognitive decline associated with Alzheimer's disease, according to a study published online February 26 in JAMA Network Open.  Discuss
Amyloid PET results prompt adults to rethink their future
February 18, 2020 -- When PET scans reveal elevated amyloid levels in cognitively normal older adults, the prospect of possibly progressing to Alzheimer's disease prompts many of them to reconsider their future priorities.  Discuss
FDG-PET/CT points to cervical cancer patient outcomes
February 13, 2020 -- Several indicators on pretreatment FDG-PET/CT scans can help predict overall survival in patients with locally advanced cervical cancer and para-aortic lymph node involvement. The markers could help clinicians steer patients toward more aggressive treatment, according to a February 7 study in Journal of Nuclear Medicine.  Discuss
Special Feature
Men greatly outnumber women in academic nuclear medicine

The under-representation of women in academic diagnostic radiology has had a ripple effect in nuclear medicine, where men outnumber women by almost 6-to-1 in professorial and leadership positions in the U.S. and Canada. Read more

Conferences
PET/CT Imaging 2020
April 24-25
Las Vegas, Nevada United States
Eastern Neuroradiological Society (ENRS) 2020 Annual Meeting
August 27-30
Burlington, Vermont United States
Vancouver Imaging Review: Head to Toe
September 24-26
Vancouver, British Columbia Canada